Canndoc
Manufacturing · Israel · 201-500 Employees
View Company Info for Free
Overview
Headquarters
85 Medinat ha-Yehudim Herzliya St, Tel A...Phone Number
+972 774605012Website
www.intercure.coRevenue
$68.3 MillionStock Symbol
INCRIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Canndoc
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.Explore more
Canndoc Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Canndoc your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Canndoc launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Canndoc recently announced quarterly report
Canndoc, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Canndoc has new funding data
Congratulate Masked Content for being promoted to Masked Content at Canndoc
Click to see if Canndoc had a recent Job posting/layoffs
Check if Canndoc has recently received funding, and reach out quickly before it becomes old news!
Check out if Canndoc is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Canndoc as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Canndoc is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Canndoc is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Canndoc.
Canndoc financials insights
Gather financial insights about Canndoc, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$18M
Canndoc Tech Stack
A closer look at the technologies used by Canndoc
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Person-Based
Executive Move
Executive Moves, Board of Directors
Canndoc News & Media
InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement
NEW YORK and HERZLIYA, Israel, March 03, 2026 (GLOBE NEWSWIRE) -- InterCure Ltd. (Nasdaq: INCR) (TASE: INCR) (“InterCure” or the “Company”) today announced that on February 25, 2026 the Company received a written notice (the “Notice”) from the Nasdaq Stock Market LLC indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(2), as the Company’s closing bid price for its ordinary shares, or Ordinary Shares, was below $1.00 per share for theInterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million
InterCure reports preliminary estimated revenue of NIS 265 million for 2025 and positive Adjusted EBITDA2, marking its twelfth consecutive half-year of positive Adjusted EBITDA.InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million
InterCure reports preliminary estimated revenue of NIS 265 million for 2025 and positive Adjusted EBITDA, marking its twelfth consecutive half-year of positive Adjusted EBITDA.InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation
Agreements formalize research partnership combining InterCure’s global pharmaceutical platform with Cannasoul’s world-class analytics and scientific innovation
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Canndoc
Sign Up For FreeTo access detailed company insights
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed... Read More
